Epilepsy

Disease-a-Month

Volumn 49, Issue 7, 2003, Pages 426-478

  Shneker, Bassel F ^a   Fountain, Nathan B ^b   Orlowski, Janis M ^c  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; AMANTADINE; ANTICONVULSIVE AGENT; BROMIDE; CARBAMAZEPINE; CLOMIFENE; CLOMIFENE CITRATE; CLONAZEPAM; CLORAZEPATE; CLORAZEPATE DIPOTASSIUM; CORTICOTROPIN; DIAZEPAM; ETHOSUXIMIDE; ETHOTOIN; ETIRACETAM; FELBAMATE; GABAPENTIN; LAMOTRIGINE; MEPHENYTOIN; MESUXIMIDE; METHYLPHENOBARBITAL; OXCARBAZEPINE; PEGANONE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TIAGABINE; TOPIRAMATE; TRIMETHADIONE; UNINDEXED DRUG; VALPROATE SEMISODIUM; VALPROIC ACID; ZONISAMIDE;

AGITATION; ALOPECIA; ANOREXIA; APLASTIC ANEMIA; ATAXIA; BLOOD DYSCRASIA; BRAIN REGION; CEREBELLAR ATAXIA; COGNITIVE DEFECT; DEPRESSION; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE PREDISPOSITION; DRUG COST; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG HALF LIFE; DRUG TOLERABILITY; ELECTROENCEPHALOGRAPHY; EPILEPSY; EPILEPTIC STATE; FAMILY HISTORY; FOLIC ACID DEFICIENCY; GENERALIZED EPILEPSY; GLAUCOMA; HEADACHE; HEPATITIS; HIGH RISK PATIENT; HIRSUTISM; HUMAN; HYPERACTIVITY; HYPERPLASIA; HYPERSENSITIVITY; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; INSOMNIA; KETOGENIC DIET; LABORATORY TEST; LEARNING DISORDER; LEUKOPENIA; LUMBAR PUNCTURE; MACROCYTIC ANEMIA; NAUSEA; NEPHROLITHIASIS; NEURAL TUBE DEFECT; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PANCREATITIS; PERIPHERAL NEUROPATHY; PHYSICAL EXAMINATION; PROGNOSIS; RASH; RECURRENT DISEASE; REVIEW; SEDATION; SEIZURE; SIDE EFFECT; STEVENS JOHNSON SYNDROME; SWEATING; SYNDROME DELINEATION; TEMPORAL LOBE EPILEPSY; THROMBOCYTOPENIA; TOXIC EPIDERMAL NECROLYSIS; TREATMENT OUTCOME; TREMOR; VAGUS NERVE STIMULATION; WEIGHT GAIN; WEIGHT REDUCTION; ADULT; CHILD; CLASSIFICATION; PATHOPHYSIOLOGY;

ADULT; ANTICONVULSANTS; CHILD; EPILEPSY; HUMANS;

EID: 0042011665     PISSN: 00115029     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0011-5029(03)00065-8     Document Type: Review

References (75)

1. Hauser WA, Annegers JF, Rocca WA. Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester, Minnesota. Mayo Clin Proc 1996;71:578-86.
2. De Boer HM. "Out of the shadows:" a global campaign against epilepsy. Epilepsia 2002;43(suppl 6):7-8.
3. Fountain NB. Seizures and epilepsy. In: Goldmann DR. Physicians' Information and Education Resource (PIER). American College of Physicians-American Society of Internal Medicine. [http://PIER. ACPOnline.org]; 2002.
4. Hauser WA, Annegers JF, Kurland LT. The prevalence of epilepsy in Rochester, Minnesota: 1940-1980. Epilepsia 1991;32:429-45.
5. Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia 1993;34:453-68.
6. Annegers JF, Rocca WA, Hauser WA. Causes of epilepsy: contributions of the Rochester epidemiology project. Mayo Clin Proc 1996;71:570-5.
7. Shinnar S, Glauser T. Febrile seizures. J Child Neurol 2002; 17(suppl 1):S44-52.
8. National Institutes of Health. Febrile seizures: long term management of children with fever-associated seizures. Summary of NIH consensus statement. Br Med J 1980;281:277-9.
9. Rosman NP. Febrile seizures. Pellock JM, Dodson WE, Bourgeois BF, editors. Pediatric epilepsy: diagnosis and treatment. 2nd ed. New York, NY: Demos Medical Publishing; 2001.
10. Dreifuss FE, Bancaud J, Henriksen O, Rubio-Donnadieu F, Seino M, Penry JK. Proposal for the revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981;22:489-501.
11. Commission of Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-99.
12. Blume WT, Luders HO, Mizrahi E, Tassinari C, van Emde Boas W, Engel J Jr. Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology. Epilepsia 2001;42:1212-8.
13. Penry JK, Porter RJ, Dreifuss RE. Simultaneous recording of absence seizures with videotape and electroencephalography: a study of 374 seizures in 48 patients. Brain 1975;98:427-40.
14. Fountain N. Manual of antiepileptic drug therapy 2002. Charlottesville (VA): University of Virginia; 2002.
15. Sander J, Hart Y, Johnson A, Shorvon S. National general practice study of epilepsy: newly diagnosed epileptic seizures. Lancet 1990;336:1257-71.
16. Krumholz A. Nonepileptic seizures: diagnosis and management. Neurology 1999; 53(suppl 2):S76-83.
17. Gates JR, Ramani V, Whalen S, Loewenson R. Ictal characteristics of pseudoseizures. Arch Neurol 1985;42:1183-7.
18. Benbadis SR, Agrawal V, Tatum WO IV. How many patients with psychogenic nonepileptic seizures also have epilepsy? Neurology 2001;57:915-7.
19. Quigg MS, Armstrong RF, Farace E, Fountain NB. Quality of life outcome is associated with cessation rather than reduction of psychogenic nonepileptic seizures. Epilepsy Behav 2002;3:455-9.
20. Lipsitz LA, Wei JY, Rowe JW. Syncope in an elderly, institutionalized population: prevalence, incidence, and associated risk. Q J Med 1985;55:45-54.
21. Day SC, Cook EF, Funkenstein H, et al. Evaluation and outcome of emergency room patients with transient loss of consciousness. Am J Med 1982;73:15-23.
22. Aminoff MJ, Scheinman MM, Griffin JC, et al. Electrocerebral accompaniments of syncope associated with malignant ventricular arrhythmias. Ann Intern Med 1988; 108:791-6.
23. Rocamora R, Kurthen M, Lickfett L, Von Oertzen J, Elger CE. Cardiac asystole in epilepsy: clinical and neurophysiologic features. Epilepsia 2003;44:179-85.
24. Ziegler DK, Hassanein RS. Specific headache phenomena: their frequency and coincidence. Headache 1990;30:152-6.
25. Fisher CM. Late-life migraine accompaniments: further experience. Stroke 1986; 17:1033-42.
26. Camfield PR, Metrakos K, Andermann F. Basilar migraine, seizures, and severe epileptiform EEG abnormalities: a benign syndrome in adolescents. Neurology 1978;28:584.
27. Gascon G, Barlow C. Juvenile migraine presenting as an acute confusional state. J Pediatr 1970;45:628-35.
28. Hosking G. Special forms: variants of migraine in childhood. Hockaday JM, editor. Migraine in childhood. London, England: Butterworths; 1988.
29. Frucht M, Quigg M, Schwaner C, Fountain N. Distribution of seizure precipitants among epilepsy syndromes. Epilepsia 2000;41:1534-9.
30. Mahowland MW, Schenck CH. Sleep disorders. Engel J, Pedley TA, editors. Epilepsy: a comprehensive textbook. Philadelphia, Pa: Lippincott-Raven; 1997: 2705-2715.
31. Turnbull TL, Vanden Hoek TL, Howes DS, Eisner RF. Utility of laboratory studies in the emergency department patient with a new onset seizure. Ann Emerg Med 1990;19:373-7.
32. Salinsky M, Kanter R, Dasheiff RM. Effectiveness of multiple EEGs in supporting the diagnosis of epilepsy: an operational curve. Epilepsia 1987;28:331-4.
33. Casino GD, Trenery MR, So EL, et al. Routine EEG and temporal lobe epilepsy: relation to long-term EEG monitoring, quantitative MRI, and operative outcome. Epilepsia 1996;37:651-6.
34. Delago-Escueta AV, Enrile-Bascal F. Juvenile myoclonic epilepsy of Janz. Neurology 1984;34:285-94.
35. Gregory RP, Oates T, Merry RT. Electroencephalogram epileptiform abnormalities in candidates for aircrew training. Electroencephalogr Clin Neurophysiol 1993;86:75-7.
36. Trojaborg W. EEG abnormalities in 5,893 jet pilot applicants registered in a 20-year period. Clin Electroencephalogr 1992;23:72-8.
37. Everett WD, Akhavi MS. Follow-up of 14 abnormal electroencephalograms in asymptomatic U.S. Air Force Academy cadets. Aviat Space Environ Med 1982;53: 277-80.
38. Zivin L, Marsan CA. Incidence and prognostic significance of "epileptiform" activity in the EEG of non-epileptic subjects. Brain 1968;91:751-78.
39. Fountain NB, Kim JS, Lee SI. Sleep deprivation activates epileptiform discharges independent of the activating effects of sleep. J Clin Neurophysiol 1998;15:69-75.
40. Quigg M, Shneker B, Domer P. Current practice in administration and clinical criteria of emergent EEG. J Clin Neurophysiol 2001;18:162-5.
41. Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: neuroimaging in the emergency patient presenting with seizure. Summary statement. Neurology 1996;47:288-91.
42. Bronen RA, Fulbright RK, Spencer DD, Spencer SS, Kim JH, Lange RC, et al. Refractory epilepsy: comparison of MR imaging, CT and histopathological findings in 177 patients. Radiology 1996;201:97-105.
43. Reynolds EH. Early treatment and prognosis of epilepsy. Epilepsia 1987;28:97-106.
44. Sutula TP, Herman B. Progression of mesial temporal lobe epilepsy. Ann Neurol 1999;45:553-6.
45. Sander JW. Some aspects of prognosis of the epilepsies: a review. Epilepsia 1993;34:1007-16.
46. Musicco A, Beghi E, Solari A, Viani F. The treatment of first tonic-clonic seizure does not improve the prognosis of epilepsy. First Seizure Trial Group. Neurology 1997;49:991-8.
47. Shinnar S, Berg AT, Moshe SL, O'Dell C, et al. The risk of seizure recurrence after a first unprovoked afebrile seizure in childhood: an extended follow-up. Pediatrics 1996;98:216-25.
48. Shinnar S, Berg A, O'Dell C, Newstin D, Moshe S, Huaser WA. Predictors of multiple seizures in a cohort of children prospectively followed from the time of their first unprovoked seizure. Ann Neurol 2000;48:140-7.
49. Hauser WA, Rich SS, Annegers JF, Elving Anderson V. Seizure recurrence after a 1st unprovoked seizure: an extended follow-up. Neurology 1990;40:1163-70.
50. Hauser WA, Rich SS, Lee JRJ, Annegers JF, Elving Anderson V. Risk of recurrent seizures after two unprovoked seizures. N Engl J Med 1998;338:429-34.
51. Beghi E, Berg AT, Hauser WA. Treatment of single seizures. Engel J, Pedley TA, editors. Epilepsy: a comprehensive textbook. Philadelphia, Pa: Lippincott-Raven; 1997:1287-1294.
52. Collaborative Group for Epidemiology of Epilepsy. Adverse reactions to antiepileptic drugs: a multicenter survey of clinical practice. Epilepsia 1986;27:323-30.
53. Scott DF. The history of epileptic therapy: an account of how medication was developed. New York, NY: Parthenon Publising Group; 1993.
54. Brodie MJ. Dichter MA. Antiepileptic drugs. N Engl J Med 1996;334:168-75.
55. Dichter MA, Brodie MJ. New antiepileptic drugs. N Engl J Med 1996;334:1583-90.
56. Marson AG, Kadir ZA, Hutton JL, Chadwick DW. The new antiepileptic drugs: a systematic review of their efficacy and tolerability. Epilepsia 1997;38:859-80.
57. Cramer JA, French J. Quantitative assessment of seizure severity for clinical trials: a review of approaches to components. Epilepsia 2001;42:119-29.
58. Mattson RH, Cramer JA, Collins JF, et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonicclonic seizures. N Engl J Med 1985;313:145-51.
59. Mattson RH, Cramer JA, Collins JF, et al. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group. N Engl J Med 1992;327:765-71.
60. Brodie MJ, Richens A, Yuen AW. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group. Lancet 1995;345:476-9.
61. Steiner TJ, Dellaportas CI, Findley LJ, Gross M, Gibberd FB, Perkin GD, et al. Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin. Epilepsia 1999;40:601-7.
62. Bill PA, Vigonius U, Pohlmann H, Guerreiro CA, Kochen S, Saffer D, et al. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy. Epilepsy Res 1997;27:195-204.
63. Christe W, Kramer G, Vigonius U, Pohlmann H, Steinhoff BJ, Brodie MJ, et al. A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy. Epilepsy Res 1997;26:451-60.
64. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL. How often is medication taken as prescribed? A novel assessment technique. JAMA 1989; 261(22):3273-3277.
65. Fountain NB, May AC. Epilepsy and athletics. Clin Sports Med 2003;22:1-12.
66. Farhat G, Yamout B, Mikati MA, Demirjian S, Sawaya R, El-Hajj Fuleihan G. Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology 2002;58:1348-53.
67. NIH Conference. Curing epilepsy: hope for the future. http://www.ninds.nih.gov/news_and_events/_conference_curing_epilepsy_ summary.htm.
68. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000;342:314-9.
69. Wiebe S, Blume WT, Girvin JP, Eliasziw M. A randomized controlled trial of surgery for temporal lobe epilepsy. N Engl J Med 2001;345:311-8.
70. Fisher RS, Handforth A. Reassessment: vagus nerve stimulation for epilepsy. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 1999;53:666-9.
71. Lefevre F, Aronson N. Ketogenic diet for the treatment of refractory epilepsy in children: a systematic review of efficacy. Pediatrics 2000;105:E46.
72. Fountain NB, Lothman EW. Pathophysiology of status epilepticus. J Clin Neurophysiol 1995;12:326-42.
73. Lowenstein DH, Bleck T, Macdonald RL. It's time to revise the definition of status epilepticus. Epilepsia 1999;40:120-2.
74. Kaplan PW. Behavioral manifestations of nonconvulsive status epilepticus. Epilepsy Behav 2002;3:122-39.
75. Shneker BF, Fountain NB. Etiology-specific morbidity and mortality of nonconvulsive status epilepticus. Epilepsia 2000;41(Suppl7):251.